caprylates has been researched along with Atrophy in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Dai, J; Guo, H; Sheng, N; Wang, J; Zhang, H | 1 |
Abedi-Valugerdi, M; Bogdanska, J; Butenhoff, JL; Chang, SC; DePierre, JW; Ehresman, DJ; Nelson, BD; Qazi, MR; Xia, Z | 1 |
Li, A; Li, X; Yang, J; Yang, Q | 1 |
Akiyama, T; Iba, T; Kaneshiro, Y; Kidokoro, A; Ohno, Y; Yagi, Y | 1 |
Depierre, JW; Xie, Y; Yang, Q | 1 |
DePierre, JW; Eriksson, AM; Nelson, BD; Xie, Y; Yang, Q | 1 |
6 other study(ies) available for caprylates and Atrophy
Article | Year |
---|---|
Perfluorooctanoic acid (PFOA) exposure induces splenic atrophy via overactivation of macrophages in male mice.
Topics: Animals; Atrophy; Caprylates; Fluorocarbons; Macrophages; Male; Mice | 2021 |
The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARa
Topics: Alkanesulfonic Acids; Animals; Atrophy; B-Lymphocytes; Body Weight; Caprylates; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Flow Cytometry; Fluorocarbons; Immunophenotyping; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Organ Size; PPAR alpha; Spleen; T-Lymphocytes; Thymus Gland | 2009 |
[Effects of peroxisome proliferators PFOA on immune system of mice].
Topics: Animals; Atrophy; B-Lymphocytes; Caprylates; Cell Cycle; Fluorocarbons; Immune System; Male; Mice; Mice, Inbred C57BL; Peroxisome Proliferator-Activated Receptors; Peroxisome Proliferators; T-Lymphocytes | 2006 |
Total parenteral nutrition supplemented with medium-chain triacylglycerols prevents atrophy of the intestinal mucosa in septic rats.
Topics: Animals; Atrophy; Bacterial Translocation; Caprylates; Escherichia coli; Fatty Acids, Nonesterified; Intestinal Mucosa; Lipopolysaccharides; Male; Nutritional Status; Parenteral Nutrition, Total; Rats; Rats, Wistar; Sepsis; Survival Rate; Triglycerides | 1998 |
Effects of peroxisome proliferators on the thymus and spleen of mice.
Topics: Animals; Aspirin; Atrophy; B-Lymphocytes; Caprylates; Cell Cycle; Cell Division; Diethylhexyl Phthalate; DNA; Fluorocarbons; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nafenopin; Peroxisome Proliferators; Pyrimidines; Spleen; T-Lymphocytes; Thymus Gland | 2000 |
Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice.
Topics: Animals; Atrophy; Body Weight; Caprylates; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Fluorocarbons; Hypertrophy; Liver; Male; Mice; Mice, Inbred C57BL; Models, Animal; Organ Size; Peroxisome Proliferators; Peroxisomes; Phenotype; Spleen; Substance Withdrawal Syndrome; Thymus Gland; Time Factors | 2001 |